Slingshot members are tracking this event:

Phase 3 RELEASE-1 study of EN3835 in the Treatment of EFP (Cellulite) in Women expected to be complete in August 2018

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 02, 2018
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords En3835, Release-1